Related Experiment Video
Updated: Aug 15, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
Organ damage in shock, disseminated intravascular coagulation, and stroke
1Dept. of Surgery, Texas Tech University, School of Medicine, El Paso 79906.
Insights
Disseminated intravascular coagulation (DIC) can cause organ failure. Fibrinolytic therapy shows promise in restoring blood flow and preventing organ damage, potentially aiding stroke treatment.
Area of Science:
- Medical Science
- Hematology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a serious condition that can lead to multiple organ failure due to capillary occlusion.
- The lungs, liver, kidneys, gut, heart, and brain are particularly vulnerable to DIC-induced damage, including focal brain necrosis.
Purpose of the Study:
- To evaluate the efficacy of fibrinolytic therapy in restoring blood flow to capillaries affected by DIC.
- To explore the potential of fibrinolytic agents in preventing organ failure and treating other forms of intravascular coagulation, such as stroke.
Main Methods:
- Administration of fibrinolytic therapy, often in low intravenous doses over 24 hours.
- Monitoring of blood flow restoration, organ function (lungs, liver, kidneys), and coagulation mechanisms.
Main Results:
- Fibrinolytic therapy successfully restored significant blood flow to lung capillaries, leading to improved lung function.
- Early administration of fibrinolytic therapy (within four hours of trauma) prevented liver and kidney failure.
- Low-dose intravenous fibrinolytic therapy showed minimal impact on the coagulation mechanism, with no significant bleeding concerns.
Conclusions:
- Fibrinolytic therapy is effective in restoring capillary blood flow and preventing organ damage in DIC.
- The findings suggest that plasminogen activators may be a viable treatment for intravascular coagulation in the brain, including stroke.
Abstract:
Disseminated intravascular coagulation (DIC) may cause multiple organ failure. Although DIC may cause capillary occlusion in any and all organs, the lungs, liver, kidneys, gut, heart and brain are particularly affected. Focal brain necrosis can also be caused by DIC. Fibrinolytic therapy will often restore significant blood flow to the capillaries of the lungs. This results in significant increase in lung function because the lung is more resistant to actual necrosis and will resume function once circulation is restored. Administration of fibrinolytic therapy will also prevent liver and kidney failure if started within four hours after trauma. This therapy, when given in low doses intravenously over a twenty-four hour period, has little effect on the coagulation mechanism, and abnormal bleeding, therefore, has not been a concern. It is speculated that if plasminogen activators are effective and safe for treating the intravascular clots of DIC, then perhaps they would be effective in treating other types of intravascular coagulation in the brain, such as various types and degrees of stroke.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

